AVAV Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
["Not a good buy right now for an impatient trader: price is still below the key pivot (~303) with bearish momentum (MACD < 0) and downside-biased pattern odds over the next day/week.", "Near-term risk/reward is unattractive: options are pricing extreme volatility (IV percentile ~99.6), raising the chance of sharp swings and post-move premium collapse.", "Fundamentals/news are supportive longer-term (defense/drone tailwinds, new $75M Air Force task order), but heavy insider selling and margin/earnings deterioration argue against chasing now."]
["Trend/Momentum: MACD histogram -8.9 (below 0) = bearish; negative but contracting suggests downside momentum may be slowing, not reversing yet.", "RSI(6) 37.4: weak/soft momentum, not clearly oversold; doesn\u2019t yet signal a high-conviction bounce.", "Levels: price (289 pre-market) is below Pivot 303.4; overhead resistance at 303.4 then 334.2. Key supports at 272.6 then 253.6.", "Setup implication: higher-probability entry would typically come after reclaiming/holding above ~303, or a cleaner test of support near ~272\u2014neither is confirmed now.", "Quant pattern read-through: similar-pattern stats imply downside bias (60% chance of -3.24% next day; -4.16% next week)."]
reinforce institutional confidence in the theme."]
with MACD still bearish; near-term statistical pattern skew is negative.", "Options market pricing: extremely high IV increases the chance of whipsaws and unfavorable premium dynamics."]
["Latest quarter: 2026/Q2.", "Revenue: $472.5M, +150.72% YoY (strong top-line growth).", "Profitability: Net income -$17.10M (down -326.74% YoY) and EPS -$0.34 (down -225.93% YoY) indicate earnings deterioration despite revenue surge.", "Margins: Gross margin 22.03%, down -43.61% YoY\u2014suggests mix/cost/integration headwinds are overwhelming growth in the near term.", "Upcoming catalyst: QJAN 2026 earnings on 2026-03-05 (AH), which can reset expectations materially."]
["Recent trend: ratings remain broadly positive (Buy/Overweight/Outperform) with some price targets trimmed after Q2, but still well above current price; KeyBanc most recently raised PT to $330 (Overweight).", "Pros (Wall St. bull case): leverage to defense/drone spending, strong backlog/pipeline conversion potential, international demand, and strategic positioning in defense tech.", "Cons (Wall St. bear case): near-term EBITDA/FCF misses and cash-flow concerns noted by some firms; valuation sensitivity and execution risk given margin compression.", "Influential/political trades: no recent congress trading data available; no politician activity provided in the dataset."]
